Literature DB >> 14308801

METASTATIC CARCINOMA OF THE MALE BREAST: REMISSION BY ADRENALECTOMY.

J S MCLAUGHLIN, H C HULL, F ODA, R W BUXTON.   

Abstract

Keywords:  ADRENALECTOMY; BREAST NEOPLASMS; NEOPLASM METASTASIS; PALLIATIVE TREATMENT; SEX

Mesh:

Year:  1965        PMID: 14308801      PMCID: PMC1476806          DOI: 10.1097/00000658-196507000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Operative treatment of adrenal cortical hyperfunctioning diseases.

Authors:  M A HAYES; I S GOLDENBERG
Journal:  Ann Surg       Date:  1961-12       Impact factor: 12.969

2.  The treatment of cancer of the male breast, especially inoperable, by ablative surgery (orchiectomy, adrenalectomy, hypophysectomy) and the hormone therapy with estrogens and corticosteroids: an analysis of 42 patients.

Authors:  N TREVES
Journal:  Acta Unio Int Contra Cancrum       Date:  1959

3.  [5-year survival following adrenalectomy in a male patient with advanced breast cancer].

Authors:  H KOLODZIEJSKA; A MARCZYNSKA; J SKOLYSZEWSKI
Journal:  Nowotwory       Date:  1962 Apr-Jun

4.  Cancer of the male breast treated by adrenalectomy.

Authors:  T L DAO
Journal:  Surg Clin North Am       Date:  1955-12       Impact factor: 2.741

5.  Indications for adrenalectomy or hypophysectomy in advanced breast cancer.

Authors:  M DOUGLAS
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1957

6.  Effect of surgical Addison's disease on advanced carcinoma of the breast and prostate.

Authors:  S G TAYLOR; N ECKLES; D P SLAUGHTER; J H McDONALD
Journal:  Cancer       Date:  1953-09       Impact factor: 6.860

7.  Endocrine ablation in disseminated mammary carcinoma.

Authors:  I MACDONALD
Journal:  Surg Gynecol Obstet       Date:  1962-08
  7 in total
  1 in total

1.  Hemodynamics of the isolated perfused pig liver: metabolism according to routes of perfusion and rates of flow.

Authors:  T Drapanas; R Zemel; J O Vang
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.